Healio

Tobramycin inhalation solution safe for bronchiectasis with Pseudomonas aeruginosa

Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...
Medindia

PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF

MONTEREY, Calif., Nov. 10 PARI Pharma GmbH hassuccessfully completed Phase I and Phase II clinical trials comparing itsproprietary PARI Tobramycin 100 (150mg/1.5mL) formulation delivered via ...
Medscape

Aerosolized Antibiotics in Cystic Fibrosis: Current and Future Trends

Practical considerations for the evaluation of aerosolized antibiotics include both biochemical (microbial spectrum and pharmacokinetics/pharmacodynamics) and device ...
FierceBiotech

Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden f

Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients CHMP supports approval of TOBI Podhaler, a ...
Monthly Prescribing Reference

Kitabis Pak Access Now Expanded for Many States

Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...
Yahoo Finance

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of ...
FiercePharma

FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US

FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US - TOBI Podhaler is indicated for certain cystic fibrosis (CF) ...
Mena FN

Ritedose Now Offers The Largest Nebulized Drug Portfolio In The U.S.: FDA Approves The Company To Manufacture Generic Tobramycin Inhalation Solution

-Antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose ) announced that ...